Tuberculosis (TB) is an AIDS-defining illness. It is still a significant cause of illness and death in people with HIV around the world.

Tuberculosis and HIV: latest news

Tuberculosis and HIV resources

  • Tuberculosis

    Tuberculosis (TB) is an infection that usually affects the lungs.It can be very serious, particularly for people living with HIV who have a low CD4 count.TB can...

    From: Factsheets

    Information level Level 2
  • TB and HIV

    If HIV has weakened your immune system, you are more vulnerable to tuberculosis (TB). TB is an infection caused by bacteria. It is a serious...

    From: The basics

    Information level Level 1
  • How TB is passed on

    The bacteria that cause tuberculosis (TB) can sometimes pass from one person to another through the air. TB bacteria can sometimes be spread through the...

    From: The basics

    Information level Level 1
  • Treatment for TB and HIV

    If tuberculosis (TB) is making you ill and you also have HIV, then you usually need to take treatment for both TB and HIV.You can...

    From: The basics

    Information level Level 1
  • Diagnosed with HIV at a low CD4 count

    NAM's factsheet on being diagnosed with HIV when already at a low CD4 cell count...

    From: Factsheets

    Information level Level 2

Tuberculosis and HIV features

Tuberculosis and HIV in your own words

Tuberculosis and HIV news from aidsmap

More news

Tuberculosis and HIV news selected from other sources

  • Tuberculosis rates in England hit lowest recorded levels

    New data released by Public Health England reveal that the number of people diagnosed with tuberculosis In England is at its lowest level since the 1990s.

    16 October 2018 | Public Health England
  • What to expect from the world’s first high-level UN meeting on TB

    On Wednesday, heads of states will sign the first UN declaration on the most deadly infectious disease on earth: TB. The ink is mostly dry on the 16-page agreement, but what’s not in the final version — and who is likely to snub its signing — tell their own story.

    25 September 2018 | Bhekisisa
  • New roadmap to prevent and treat tuberculosis in children and adolescents

    A new action plan outlining measures to prevent and treat tuberculosis (TB) in children and adolescents was launched today by global tuberculosis (TB) leadership in advance of the United Nations General Assembly High-Level meeting on TB.

    25 September 2018 | UNICEF
  • Johnson & Johnson Announces 10-year Initiative to Help End Tuberculosis

    With the goal of saving an estimated 1.8 million lives and preventing 12 million new TB infections in the next decade, Johnson & Johnson will work with partners to improve detection of undiagnosed cases of TB, broaden access to its novel medicine for multidrug-resistant TB (MDR-TB), and accelerate research & development (R&D) to discover next-generation TB treatments.

    25 September 2018 | Johnson & Johnson press release
  • Fighting tuberculosis – the disease that doesn’t go away

    Another year, another Global Tuberculosis (TB) Report that tracks too slow progress towards ending TB, one of the world’s oldest and deadliest diseases.

    24 September 2018 | Avert
  • WHO report warns efforts to end TB are falling short

    The number of new tuberculosis (TB) cases continued to decline in 2017, and fewer people died from the disease, according to the World Health Organization's (WHO's) 2018 Global TB Report. But efforts to make the world's deadliest infectious disease a "disease of the past" need to be ramped up, agency officials said today.

    19 September 2018 | Center for Infectious Disease Research and Policy
  • SimpliciTB Clinical Trial Launched with First Patients in Tbilisi, Georgia

    New pivotal trial examines potential of BPaMZ regimen to shorten treatment for tuberculosis and multidrug-resistant tuberculosis.

    28 August 2018 | TB Alliance
  • WHO announces landmark changes in MDR-TB treatment regimens

    Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant tuberculosis (MDR-TB) are expected, following key changes in MDR-TB treatment announced by WHO today.

    20 August 2018 | World Health Organization
  • The 2018 Pipeline Report

    Welcome to the 2018 Pipeline Report, Treatment Action Group’s annual review of therapeutics, diagnostics, vaccines, and preventive technologies in development for HIV, hepatitis C virus (HCV), and tuberculosis, along with immune-based and gene therapies and research toward a cure for HIV.

    24 July 2018 | TAG
  • High rates of HIV and diabetes raise the risk of TB for South Africans

    The Yale-led research team analyzed health data on more than 7,000 patients screened for both chronic and infectious diseases. After adjusting for demographic and socioeconomic factors, the researchers found that people with either HIV or diabetes were more likely to also have TB. They also discovered that having both diseases further compounded the risk for developing TB symptoms. This is one of the first studies to demonstrate the possible synergism between HIV and diabetes to increase risk of TB, the researchers said.

    20 June 2018 | Yale News
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.